We are MagForce NT GmbH.

Since 1997 we specialize in developing advanced nanomedicine for cancer therapies.

We are forging new paths to treat cancer successfully and gently: With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients all over the world. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for the treatment of recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumor were able to improve their quality of life after having used our technology.

• 1997 Foundation of our headquarters in Berlin
• 9 International patent families, approx. 100 individual patents and 65 patent-pending
• 2011 Breakthrough regulatory approval in the EU and first patient treatments

Certifications

• NanoTherm® AS1 is certified by DNV MEDCERT GmbH (0482)
• MagForce NT GmbH is ISO 13485 certified by DEKRA Netherlands B.V. (0344)

Careers

There are no current openings at this time.